In light of ACM Biolabs's recent breakthrough and the efficacy of its COVID-19 vaccine against delta and #omicron variants, we interviewed Alexander Breidenbach, its Chief Development Officer on the overall challenges and intricacies of vaccine research and its role in preventing infectious diseases.
